about
Limited-field radiation for bifocal germinoma.Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsCNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.Widespread osteonecrosis in children with leukemia revealed by whole-body MRI.Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis.Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience.Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.Medulloblastoma in children under the age of three years: a retrospective Canadian review.Current treatment approaches for infants with malignant central nervous system tumors.Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma.Spinal cord tumors in children under the age of 3 years: a retrospective Canadian review.The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience.Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience.Neoadjuvant chemotherapy reduces blood loss during the resection of pediatric choroid plexus carcinomas.Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children.Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature.A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.Ependymoma in children under the age of 3 years: a report from the Canadian Pediatric Brain Tumour Consortium.Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.Survival of children with medulloblastoma in Canada diagnosed between 1990 and 2009 inclusive.Low grade astrocytoma in children under the age of three years: a report from the Canadian pediatric brain tumour consortium.EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.Patterns of enrollment of infants with central nervous system tumours on cooperative group studies: a report from the Canadian Pediatric Brain Tumour Consortium.TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.Choroid plexus tumors in children less than 36 months: the Canadian Pediatric Brain Tumor Consortium (CPBTC) experience.Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis.Sustained response to weekly vinblastine in 2 children with pilomyxoid astrocytoma associated with diencephalic syndrome.AT-07SUCCESSFUL TREATMENT OF ATRT PATIENTS WITHOUT ADJUVANT RADIATION: A MULTI INSTITUTIONAL CANADIAN EXPERIENCE.Post-chemotherapy maturation in supratentorial primitive neuroectodermal tumors.AT-03ATYPICAL TERATOID RHABDOID TUMORS IN THE FIRST YEAR OF LIFE: SHOULD WE TREAT?AT-21INTEGRATED (EPI)GENOMIC ANALYSES IDENTIFY SUB-GROUP SPECIFIC THERAPEUTIC TARGETS IN CNS RHABDOID TUMORS.EPN-38RELAPSE PATTERNS IN PEDIATRIC INTRACRANIAL EPENDYMOMA: A CANADIAN EXPERIENCE.Patient-Reported Outcomes in Psychological Treatment for an Adolescent Oncology Patient: A Case Report.Supratentorial primitive neuroectodermal tumors: a Canadian pediatric brain tumor consortium report.Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.Incidence of medulloblastoma in Canadian children.
P50
Q31034039-6341D7EA-B9B5-4CCF-B73C-02A7446CD7A2Q33882326-683AEEA1-A524-4CDD-A9CC-DC8F6FC72122Q34157312-C60A6198-1A73-4085-9CC1-33B7DABB0FC9Q36116446-9F1BD8B3-7DAB-49AD-A47E-83BA45420340Q36381725-FC06539F-7789-4F8A-9FAD-AB9A366DA82CQ36737213-C880C59C-E95D-4777-9903-B12982D24316Q36779592-200872FF-7340-4428-958C-6521044A0343Q37039851-56A26F25-3DA5-4A93-BC6C-723B1C1BA9CAQ37382230-307CF874-8784-4EFF-9656-7391B5583D1CQ37431084-E65167FB-40A9-4351-8ADA-347499A16FD2Q37580472-D0380F26-6B0C-43FB-B708-D78C47790ACFQ37761927-B134E6C3-8586-42A9-8178-7B7558225619Q37831186-43211EF0-A43F-4BD2-866E-4C5F28B19C53Q38267747-8E6D32F2-BFA9-4E11-94E0-8D82C621CBE4Q38383177-054A9735-B072-4ADE-822E-42547E69673BQ38453336-D9EA946F-CC35-4E1E-BC67-4AE0BD5FBC2FQ38640283-EBC131E1-C678-448D-B5B0-79C7A22DFEBFQ38653412-136B4E10-1DC1-4221-B0C4-0E535546766CQ38838969-E28E3D13-141F-4D17-810B-D11AC454F8F1Q39012914-BB9CEA8D-6ED9-49B3-89C3-621D0C1545E3Q39047678-5DA135EC-1C1D-4B3A-B89C-C020638E4D1FQ39249798-6247B54D-C141-4D6F-AD98-1CFCF2E8D7D3Q39795085-D871E4F4-D472-492D-90FD-BA2AD5291A2AQ40889732-6A73C406-513A-41CF-8343-333C154EB3CCQ40945899-2FB3CA89-3FC5-436F-9F50-2C1C76C51C53Q42175070-AD47DD09-E5C9-4BE1-94C9-DD5CDA52B92FQ42648113-E41ACB6A-CE1F-4FA7-BCAF-ECF9B7009F24Q43713762-F35D58C7-DA9D-4531-B915-B3FB4B1EF84BQ43862270-6952B92B-3D55-441D-9057-28EA540FE83FQ45012320-93CE4D81-14C1-429A-BC63-30BA3AF3EEEFQ45343687-B824B0EF-3E68-47F3-AFA2-0551AC48B99BQ45957931-8E2D948B-8A5C-4A3F-8438-A1C9AF85BE8BQ46156427-7BA332DE-A0F0-4132-ADE4-7D6A1B751AD9Q46347611-2D15B243-5F46-455B-BF38-D40AD8506F20Q46347906-03807549-EE04-4E56-B782-10586338F6BDQ46350093-FDBC4DFA-DE7A-4009-8116-9A3D401D32CDQ47558634-A98825C3-8097-417C-848E-E4B739A05C1CQ48111288-A2066D7C-9F90-46EC-B9AA-EDC0FE788899Q48167111-246A5D44-FFE5-4244-9CE0-A65A49ACA55DQ48600602-AC9DE870-CE3C-4A91-BF2F-D64BD8B586C1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lucie Lafay-Cousin
@ast
Lucie Lafay-Cousin
@en
Lucie Lafay-Cousin
@es
Lucie Lafay-Cousin
@nl
type
label
Lucie Lafay-Cousin
@ast
Lucie Lafay-Cousin
@en
Lucie Lafay-Cousin
@es
Lucie Lafay-Cousin
@nl
prefLabel
Lucie Lafay-Cousin
@ast
Lucie Lafay-Cousin
@en
Lucie Lafay-Cousin
@es
Lucie Lafay-Cousin
@nl
P106
P31
P496
0000-0003-4569-3499